Dr. Pruden is widely recognised for her work documenting antibiotic resistance genes as environmental contaminants, her most recent research focuses on advancing practical means of antibiotic resistance monitoring, mitigation and risk assessment in wastewater, recycled water and other water systems.

Lars Backsell, Chairman of the Board of Recipharm said: "We are delighted to present the 2020 award to Dr. Amy Pruden. Her work, which has given deeper understanding of the microbial ecology of water systems, is widely recognised and highlighted. Her work concerning antibiotic resistance is particularly interesting since this is a known challenge for the pharmaceutical industry, healthcare and agriculture sectors. Dr. Pruden's research in this area is invaluable and will no doubt go a long way to identifying exactly how antibiotic use impacts risks in relation to antimicrobial resistance."

Dr. Pruden also serves as an Associate Editor for the Journal of Environmental Science & Technology and has published more than 175 peer-reviewed manuscripts and book chapters on bioremediation, pathogens and antibiotic resistance. She is also well known for her work in advancing the study of environmental microbiomes and desiging water systems to prevent the colonization of pathogens, such as Legionella.

Commenting on the award win she said: "I am very honoured to receive this award and thank Recipharm for this recognition. Our success has really been a team effort, as tackling environmental and public health challenges requires expertise from many disciplines and perspectives. I especially would like to thank my many students for all of their hard work and dedication and I hope that this award offers some inspiration for the future." 

The prize ceremony will take place later during spring 2021 and will be set up in an appropriate format considering the development of the COVID-19 pandemic.
 

Contact information
Lars Backsell, Recipharm Chairman of the Board, +46 8 602 52 00
Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability, erik.haeffler@recipharm.com,+ 46 8 6025 285

For media enquiries, please contact Lindsay Baldry at ramarketing: lindsay@ramarketingpr.com,+ 44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr,Facebook: /ramarketingpr, Linkedin: /ramarketing

For media enquiries Virginia Tech, please contact Emily Roediger, Director of Communications and Marketing, +1 (540) 231-2108, eroedig@vt.edu

About Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm's annual turnover is approximately SEK 11 billion. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.
For more information on Recipharm and our services, please visit www.recipharm.com
 

About Recipharm's International Environmental Award             
Since Recipharm was founded in 1995, our environmental agenda has been a central part of the way we do business. It is our belief that transparency, cooperation and encouragement are necessary if we are to achieve sustainable development. In order to promote this belief, we introduced an international environmental award in 2008 for the best environmental practice or innovation within the pharmacy and health care industries or academia.

For more information visit https://www.recipharm.com/sustainability/recipharm-international-environmental-award